RNF and Betaseron® Tolerability Study
clinical trial
Press Enter · cited answer in seconds
0 sources
RNF and Betaseron® Tolerability Study
Summary
RNF and Betaseron® Tolerability Study is a clinical trial[1].
Key Facts
- RNF and Betaseron® Tolerability Study is in the country of United States[2].
- RNF and Betaseron® Tolerability Study's instance of is recorded as clinical trial[3].
- RNF and Betaseron® Tolerability Study's start time is recorded as +2006-12-31T00:00:00Z[4].
- RNF and Betaseron® Tolerability Study's end time is recorded as +2007-11-30T00:00:00Z[5].
- RNF and Betaseron® Tolerability Study's sponsor is recorded as Merck KGaA[6].
- RNF and Betaseron® Tolerability Study's main subject is recorded as sclerosis[7].
- RNF and Betaseron® Tolerability Study's main subject is recorded as multiple sclerosis[8].
- RNF and Betaseron® Tolerability Study's number of participants is recorded as {'unit': '1', 'amount': '+129'}[9].
- RNF and Betaseron® Tolerability Study's title is recorded as A Randomized, Multicenter, Two Arm, Open Label, Twelve Week Phase IIIb Study to Evaluate the Tolerability of Rebif (New Formulation) (IFN Beta-1a) and Betaseron (IFN Beta-1b) in IFN-naive Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Followed by a Single Arm, Eighty-two Week Minimum, Rebif (New Formulation) Only Safety Extension[10].
- RNF and Betaseron® Tolerability Study's short name is recorded as REFORMS[11].
- RNF and Betaseron® Tolerability Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- RNF and Betaseron® Tolerability Study's ClinicalTrials.gov ID is recorded as NCT00428584[13].
- RNF and Betaseron® Tolerability Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[14].
- RNF and Betaseron® Tolerability Study's research intervention is recorded as interferon beta-1a[15].
- RNF and Betaseron® Tolerability Study's research intervention is recorded as interferon beta-1b[16].
- RNF and Betaseron® Tolerability Study's clinical trial phase is recorded as phase III clinical trial[17].
- RNF and Betaseron® Tolerability Study's study type is recorded as interventional study[18].